| 000 | 00987 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516230003.0 | ||
| 264 | 0 | _c20150521 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1399-0004 | ||
| 024 | 7 |
_a10.1111/cge.12483 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGibson, W T | |
| 245 | 0 | 0 |
_aBeneficial metabolic phenotypes caused by loss-of-function APOC3 mutations. _h[electronic resource] |
| 260 |
_bClinical genetics _cJan 2015 |
||
| 300 |
_a31-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aApolipoprotein C-III _xgenetics |
| 650 | 0 | 4 |
_aCoronary Disease _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIschemia _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xgenetics |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 773 | 0 |
_tClinical genetics _gvol. 87 _gno. 1 _gp. 31-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cge.12483 _zAvailable from publisher's website |
| 999 |
_c24092697 _d24092697 |
||